MILNE GEORGE M JR has filed 16 insider transactions across 1 company since January 2022.
Most recent transaction: a gift of 17780 shares of Amylyx Pharmaceuticals, Inc. ($AMLX) on January 12, 2026.
Activity breakdown: 1 open-market purchase and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Not found | G | Common Stock | 17780 | $0.00 | 812,881.0000 | 109,819,569 | 2.14% | 0.02% |
| June 5, 2025 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 88,602,468 | 9999.99% | 0.03% |
| Jan. 24, 2025 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Not found | G | Common Stock | 27910 | $0.00 | 830,661.0000 | 0 | 3.25% | 0.00% |
| Sept. 3, 2024 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Not found | P | Common Stock | 100000 | $2.20 | 858,571.0000 | 0 | 13.18% | 0.00% |
| June 6, 2024 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 25, 2024 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Not found | G | Common Stock | 9100 | $0.00 | 758,571.0000 | 0 | 1.19% | 0.00% |
| Jan. 16, 2024 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Not found | G | Common Stock | 94350 | $0.00 | 767,671.0000 | 0 | 10.95% | 0.00% |
| June 8, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Director | A | Stock Option (right to buy) | 16985 | $0.00 | 16,985.0000 | 0 | 9999.99% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Director | S | Common Stock | 1916 | $32.45 | 862,021.0000 | 0 | 0.22% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Director | S | Common Stock | 33084 | $31.86 | 863,937.0000 | 0 | 3.69% | 0.00% |
| Dec. 29, 2022 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Director | G | Common Stock | 13800 | $0.00 | 897,021.0000 | 0 | 1.52% | 0.00% |
| Jan. 6, 2022 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Director | C | Series A Preferred Stock | 262282 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 6, 2022 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Director | C | Series B Preferred Stock | 384449 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 6, 2022 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Director | C | Series C-1 Preferred Stock | 19482 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 6, 2022 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Director | C | Series C-2 Preferred Stock | 23212 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 6, 2022 | Amylyx Pharmaceuticals, Inc. | $AMLX | MILNE GEORGE M JR | Director | C | Common Stock | 689425 | $0.00 | 910,821.0000 | 0 | 311.40% | 0.00% |